Table 2 Diagnostic ability of VCTE and MRI/MRE techniques to detect hepatic fibrosis and steatosis presented by AUROCs in patients with NAFLD.

From: Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD

 

Fibrosis stage

F0–1 vs. F2–4

F0–2 vs. F3–4

F0–3 vs. F4

All

MRE

0.89

0.92

0.94

VCTE

0.90

0.93

0.89

BMI < 25 kg/m2 normal

MRE

0.94

0.96

–

VCTE

0.95

0.95

–

25≦BMI < 30 kg/m2 overweight

MRE

0.85

0.87

0.95

VCTE

0.83

0.91

0.88

BMI ≥ 30 kg/m2 obese

MRE

0.88

0.95

0.95

VCTE

0.94

0.92

0.87

 

Steatosis grade

S0 vs. S1–3

S0–1 vs. S2–3

S0–2 vs. S3

All

MRI-PDFF

0.95

0.90

0.89

CAP

0.89

0.77

0.69

BMI < 25 kg/m2 normal

MRI-PDFF

0.81

0.93

0.90

CAP

0.73

0.81

0.63

25≦BMI < 30 kg/m2 overweight

MRI-PDFF

1.00

0.93

0.90

CAP

0.95

0.82

0.75

BMI ≥ 30 kg/m2 obese

MRI-PDFF

1.00

0.83

0.88

CAP

0.93

0.68

0.61

  1. CAP controlled attenuation parameter, MRE magnetic resonance elastography, MRI-PDFF magnetic resonance imaging-proton density fat fraction, VCTE vibration-controlled transient elastography.
Back to article page